News Headlines Article

Blood pressure drug recall: 32 lots of losartan recalled over small amounts of carcinogen
USA Today

Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen.

The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a company notice posted to the Food and Drug Administration’s website Wednesday.

“Based on the available information, the risk of developing cancer in a few patients following long-term use of the product cannot be ruled out,” the recall notice states.

Commands